These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 14588235)

  • 1. [Positron emission tomography in a patient with Von Recklinghausen disease and left dorsal neurofibrosarcoma].
    Ruíz-Hernández G; Hornedo-Muguiro J; Salinas-Hernández P; Pérez-Castejón MJ; Lapeña-Gutiérrez L; Montz-Andrée R; Carreras-Delgado JL
    Rev Esp Med Nucl; 2003 Nov; 22(6):418-23. PubMed ID: 14588235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone scans in neurofibromatosis: neurofibroma, plexiform neuroma and neurofibrosarcoma.
    Kloos RT; Rufini V; Gross MD; Shapiro B
    J Nucl Med; 1996 Nov; 37(11):1778-83. PubMed ID: 8917174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malignant spinal neurofibrosarcoma.
    Kett-White R; Martin JL; Jones EW; O'Brien C
    Spine (Phila Pa 1976); 2000 Mar; 25(6):752-5. PubMed ID: 10752112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hybrid whole body
    Yang M; Zhou Y; Hoxworth JM; Porter AB; Roarke MC
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):261-263. PubMed ID: 28803890
    [No Abstract]   [Full Text] [Related]  

  • 5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posterior mediastinal neurofibrosarcoma in a patient with von Recklinghausen's disease.
    Halkic N; Zeini SA; Bouchardy J; Boumghar M
    Schweiz Med Wochenschr; 1999 May; 129(21):818. PubMed ID: 10413818
    [No Abstract]   [Full Text] [Related]  

  • 7. Orbital neurofibrosarcoma: a case report.
    Tanwar RK; Kumar R; Malik S; Dhir R; Rath GK
    Indian J Pathol Microbiol; 1995 Jan; 38(1):91-4. PubMed ID: 8919474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.
    Kushner BH; Yeung HW; Larson SM; Kramer K; Cheung NK
    J Clin Oncol; 2001 Jul; 19(14):3397-405. PubMed ID: 11454888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal cord compression by tophaceous gout with fluorodeoxyglucose-positron-emission tomographic/MR fusion imaging.
    Popovich T; Carpenter JS; Rai AT; Carson LV; Williams HJ; Marano GD
    AJNR Am J Neuroradiol; 2006; 27(6):1201-3. PubMed ID: 16775264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seriously saRComa: Neurofibrosarcoma.
    Behle V; Goebeler M; Gesierich A
    Eur J Dermatol; 2016 Oct; 26(5):517-518. PubMed ID: 27789422
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical value of [18-F]] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas.
    Schwarzbach MH; Dimitrakopoulou-Strauss A; Willeke F; Hinz U; Strauss LG; Zhang YM; Mechtersheimer G; Attigah N; Lehnert T; Herfarth C
    Ann Surg; 2000 Mar; 231(3):380-6. PubMed ID: 10714631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1.
    Shahid KR; Amrami KK; Esther RJ; Lowe VJ; Spinner RJ
    J Surg Orthop Adv; 2011; 20(2):132-5. PubMed ID: 21838076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant Peripheral Nerve Sheath Tumor With Bilateral Adrenal Metastases: Role of 18F-FDG PET/CT in Response Assessment to Tyrosine Kinase Inhibitor and Liposomal Doxorubicin.
    Tripathy S; Passah A; Singhal A; Prashanth A; Kumar R
    Clin Nucl Med; 2019 Jun; 44(6):494-495. PubMed ID: 30889004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teaching NeuroImages: Intracranial malignant triton tumor: An uncommon location of a rare tumor.
    Dias AB; Cambruzzi E; Giugno CS; Miranda de Curtis R; Faria do Amaral LL; Lenhardt R
    Neurology; 2019 Mar; 92(12):e1401-e1402. PubMed ID: 30886081
    [No Abstract]   [Full Text] [Related]  

  • 15. Potential usefulness of 18F-2-fluoro-deoxy-D-glucose positron emission tomography in cervical compressive myelopathy.
    Baba H; Uchida K; Sadato N; Yonekura Y; Kamoto Y; Maezawa Y; Furusawa N; Abe Y
    Spine (Phila Pa 1976); 1999 Jul; 24(14):1449-54. PubMed ID: 10423790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastatic spinal neurofibrosarcoma.
    Sar C; Eralp L
    Arch Orthop Trauma Surg; 2002 Mar; 122(2):106-8. PubMed ID: 11880913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (18)F-FDG PET/CT in an unusual case of cardiac plexiform neurofibromatosis.
    D'souza MM; Sondhi P; D'souza P; Sharma R; Jaimini A; Pandey S; Mondal A; Tripathi RP
    Clin Nucl Med; 2015 Jun; 40(6):529-30. PubMed ID: 25706790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of FDG positron emission tomography in conjunction with MR imaging for evaluating therapy response in patients with musculoskeletal sarcomas.
    Bredella MA; Caputo GR; Steinbach LS
    AJR Am J Roentgenol; 2002 Nov; 179(5):1145-50. PubMed ID: 12388489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
    Sheikhbahaei S; Marcus C; Hafezi-Nejad N; Taghipour M; Subramaniam RM
    PET Clin; 2015 Jul; 10(3):375-93. PubMed ID: 26099673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of fluorodeoxyglucose positron emission tomography in the management of soft-tissue sarcomas.
    Lucas JD; O'Doherty MJ; Wong JC; Bingham JB; McKee PH; Fletcher CD; Smith MA
    J Bone Joint Surg Br; 1998 May; 80(3):441-7. PubMed ID: 9619933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.